Rheumatic heart disease in a developing country: Incidence and trend (Monastir; Tunisia: 2000–2013)

Belguith, Asma Sriha; Abdelkafi, Afifa Koubaa; Mhamdi, Sana El; Fredj, Manel Ben; Abroug, Héla; Salah, A. Ben; Bouanène, Inès; Hassine, Fahima; Amara, Abdelbasset; Bhiri, Sami; Derbel, A; Gamra, Habib; Maatouk, Faouzi; Soltani, M.S.

doi:10.1016/j.ijcard.2016.11.249

Cited by 19 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The homogeneous seasonal distribution of AOM admissions contrasted with the results of a study conducted in Taiwan that showed a peak from March to May, which could be related to climate differences [23]. Pharyngitis hospitalization rates were decreasing also in our sample due to the efficacy of Tunisian national program in preventing acute articular rheumatism and to the medical practice performance in primary care [27].…”

Section: Discussioncontrasting

confidence: 94%

Trends and health burden of hospitalized acute respiratory infections and impact of Haemophilus influenza immunization in a Tunisian university hospital: a twelve-year study

Fredj

Dhouib

Kacem

et al. 2020

Libyan Journal of Medicine

Self Cite

View full text Add to dashboard Cite

Background: We aimed to describe the episodes and trends of admissions for communityacquired Respiratory Infections (RI) over a 12-year period and to assess the impact of Haemophilus influenza type b (Hib) vaccine on RI admissions in children aged up to 3 years. Methods: We conducted a twelve-year retrospective observational study on all communityacquired RI admitted to Fattouma Bourguiba Hospital in Monastir Governorate (Tunisia) from 1 January 2002 to 31 December 2013. RI cases were selected from the Regional Registry of Hospital Morbidity. Data were coded according to ICD-10. To assess the impact of the Hib vaccine, three cohorts were defined based on vaccine status (unvaccinated cohort, first vaccinated cohort (VC) by monovalent form and second VC by pentavalent combination). Results: Admissions for RI represented 17.6% (CI95%: 17.3-18.1) of all communicable diseases hospitalizations (n = 6 061/34 289). The crude incidence rates (CIR) per 100,000 inh were 24.2 for upper RI (URI) and 77.5 and for Lower RI (LRI) (p < 0.0001). Pneumonias represented 53.9% of LRI. Sex-ratio (male/female) was 1.12 for URI and 1.64 for LRI (p < 0.0001). At admission, the median age was 22 years (IQR: 3-52). Admission for Pneumonia increased significantly during study period (slope 'b' = 5.16; p < 0.0001) especially in children up to 5 years old (slope 'b' = 5.53) and in elderly (slope 'b' = 2.13). Among children up to 3 years old, the CIRs per 100,000 for Hib pneumonia admission were 11.6 in Non-Vaccinated Cohort (NVC), 10.6 in Vaccinated Cohort (VC) by protocol 1 (Hib Vaccine monovalent) and 0.80 in VC by protocol 2 (pentavalent vaccine combination).The relative risk reduction was 99% for protocol 2 (p < 0.001). Conclusion: Admissions for RI in a tertiary level hospital were common with an increasing trend. The Hib immunization program, in particular the pentavalent combination, has had a positive impact on the reduction of related acute diseases.

show abstract

Section: Discussioncontrasting

confidence: 94%

Trends and health burden of hospitalized acute respiratory infections and impact of Haemophilus influenza immunization in a Tunisian university hospital: a twelve-year study

Fredj

Dhouib

Kacem

et al. 2020

Libyan Journal of Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

“…This study confirmed the epidemiological transition, showing a decrease in the majority of HCD. 31 However, a reverse trend was found for some disease categories. The healthcare system in Tunisia faces many challenges.…”

Section: Discussionmentioning

confidence: 95%

Hospitalizations for communicable diseases in a developing country: prevalence and trends—Monastir, Tunisia, 2002–2013

Fredj

Belguith

Abroug

et al. 2017

International Journal of Infectious Diseases

Self Cite

View full text Add to dashboard Cite

show abstract

“…The Addis Ababa communiqué, as follows, has since been endorsed by heads of state of the African Union and EMR countries: (1) create prospective disease registers at sentinel sites in affected countries to measure disease burden and track progress towards a reduction of mortality by 25% by the year 2025, (2) ensure an adequate supply of high-quality benzathine penicillin for the primary and secondary prevention of ARF/RHD, (3) improve access to reproductive health services for women with RHD and other non-communicable diseases (NCD), (4) decentralize technical expertise and technology for diagnosing and managing ARF and RHD (including ultrasound of the heart), (5) establish national and regional centers of excellence for essential cardiac surgery for the treatment of affected patients and training of cardiovascular practitioners of the future, (6) initiate national multi-sectorial RHD programs within the NCD control programs of affected countries, and (7) foster international partnerships with multinational organizations’ for resource mobilization, monitoring and evaluation of the program to end RHD in Africa [ 48 ]. Plans are underway to implement a roadmap to end ARF and RHD in Africa in our lifetime, and change trends and outcomes of the disease in our region and around the world [ 43 , 44 , 49 , 50 ].…”

Section: Discussionmentioning

confidence: 99%

Trends in Deaths from Rheumatic Heart Disease in the Eastern Mediterranean Region: Burden and Challenges

Abul-Fadl

Mourad

Ghamrawy

et al. 2018

JCDD

View full text Add to dashboard Cite

Rheumatic heart disease (RHD) is a preventable disease that is prevalent in developing regions of the world. Its eradication from most of the developed world indicates that this disease can be controlled and eliminated. Aim: To conduct an in-depth analysis of the trends and challenges of controlling RHD in the Eastern Mediterranean region (EMR). Methodology: Global data from the World Health Organization (WHO) data banks were retrieved for total deaths and age standardized death rate per 100,000 (ASDR) by age group, sex, and year (from 2000 to 2015). The data was compared with the five other WHO regions of the world. We also performed in-depth analysis by socio-economic groups in relation to other attributes in the region related to population growth, illiteracy, and nutritional status. Indicators of service delivery were correlated with ASDR from RHD. Findings: Prevalence of RHD in 2015 in the EMR region was one-third of that of the total deaths reported in the Asian and West Pacific regions. The total deaths for the region peaked twice: in early adulthood and again later in old age, and was higher in females than in males. There was a rising trend in deaths from RHD from 2000 to 2015. The highest total deaths were reported from Egypt, Pakistan, Iran, Afghanistan, and Yemen, representing 80% of the total death rates for the region (35,248). The highest ASDR was Afghanistan (27.5), followed by Yemen (18.78) and Egypt (15.59). The ASDR for RHD was highest in low income countries. It correlated highly, in all income groups, with anemia during pregnancy. Conclusions: Trends and patterns of deaths from RHD in the EMR have shifted to a later age group and are linked with poverty related to inequalities in development and service delivery for certain age groups and gender.

show abstract

Rheumatic heart disease in a developing country: Incidence and trend (Monastir; Tunisia: 2000–2013)

Cited by 19 publications

References 22 publications

Trends and health burden of hospitalized acute respiratory infections and impact of Haemophilus influenza immunization in a Tunisian university hospital: a twelve-year study

Trends and health burden of hospitalized acute respiratory infections and impact of Haemophilus influenza immunization in a Tunisian university hospital: a twelve-year study

Hospitalizations for communicable diseases in a developing country: prevalence and trends—Monastir, Tunisia, 2002–2013

Trends in Deaths from Rheumatic Heart Disease in the Eastern Mediterranean Region: Burden and Challenges

Contact Info

Product

Resources

About